Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melqart Asset Management is a London-based independent investment management firm founded in 2015 by Michel Massoud. The firm specializes in event-driven investment strategies, focusing on merger arbitrage, special situations, and capital markets opportunities across the capital structure. While Melqart is a multi-sector investor, it maintains significant exposure to the healthcare and biotechnology industries by investing in companies undergoing clinical catalysts, regulatory milestones, or corporate restructurings. The firm is authorized and regulated by the Financial Conduct Authority (FCA) in the United Kingdom and manages the Melqart Opportunities Fund. Its investment approach combines fundamental bottom-up analysis with a focus on risk-adjusted absolute returns. Melqart provides institutional investors with access to global event-driven opportunities with a particular emphasis on European and North American markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melqart Asset Management.